Mira 50mg Tablet, containing Mirabegron (50mg), is a once-daily, orally administered treatment for the symptoms of overactive bladder (OAB), characterized by urinary frequency, urgency, and incontinence. This medication works by selectively targeting the beta-3 adrenergic receptors in the bladder, thereby increasing the bladder's capacity to store urine and reducing the frequency and urgency of urination. Mira 50mg Tablet is indicated for adult patients who experience symptoms of OAB, including urinary frequency, urgency, and incontinence, and has been shown to significantly reduce the number of daily incontinence episodes and improve patient-reported outcomes. The recommended starting dose is 50mg once daily, and the tablet should be taken in the morning with food. Patients should be monitored for adverse reactions, including hypertension, tachycardia, and abnormal liver function tests. Contraindications include hypersensitivity to Mirabegron, severe liver impairment, and pregnancy or breastfeeding.